Background: We investigated the influence of self-reported corrected eyesight on several variables describing the perception by employees and self-employed persons of their employment. Methods: Our study was based on data from the Survey of Health, Ageing and Retirement in Europe (SHARE). SHARE is a multidisciplinary, cross-national database of microdata on health, socioeconomic status, social and family networks, collected on 31,115 individuals in 11 European countries and in Israel. With the help of ordered logistic regressions and binary logistic regressions, we analyzed the influence of perceived visual impairment – corrected by 19 covariates capturing socioeconomic and health- related factors – on 10 variables describing the respondents’ employment situation. Results: Based on data covering 10,340 working individuals, the results of the logistic and ordered regressions indicate that respondents with lower levels of self-reported general eyesight were significantly less satisfied with their jobs, felt they had less freedom to decide, less opportunity to develop new skills, less support in difficult situations, less recognition for their work, and an inadequate salary. Respondents with a lower eyesight level more frequently reported that they feared their health might limit their ability to work before regular retirement age and more often indicated that they were seeking early retirement. Conclusions: Analysis of this dataset from 12 countries demonstrates the strong impact of self-reported visual impairment on individual employment, and therefore on job satisfaction, productivity, and well-being.

Keywords:
Visual impairment, Employment, Job satisfaction, Retirement, Salary
1.
Chia EM, Mitchell P, Ojaimi E, Rochtchina E, Wang JJ: Assessment of vision-related quality of life in an older population subsample: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2006;13:371–377.
2.
Chia EM, Mitchell P, Rochtchina E, Foran S, Wang JJ: Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study. Br J Ophthalmol 2003;87:392–395.
3.
Varma R, Wu J, Chong K, Azen SP, Hays RD: Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 2006;113:1846–1853.
4.
Vu HT, Keeffe JE, McCarty CA, Taylor HR: Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol 2005;89:360–363.
5.
Sloan FA, Ostermann J, Brown DS, Lee PP: Effects of changes in self-reported vision on cognitive, affective, and functional status and living arrangements among the elderly. Am J Ophthalmol 2005;140:618–627.
6.
Satariano WA, MacLeod KE, Cohn TE, Ragland DR: Problems with vision associated with limitations or avoidance of driving in older populations. J Gerontol B Psychol Sci Soc Sci 2004;59:S281–S286.
7.
Freeman EE, Munoz B, Turano KA, West SK: Measures of visual function and their association with driving modification in older adults. Invest Ophthalmol Vis Sci 2006;47:514–520.
8.
Javitt JC, Zhou Z, Willke RJ: Association between vision loss and higher medical care costs in Medicare beneficiaries. Costs are greater for those with progressive vision loss. Ophthalmology 2007;114:238–245.
9.
Wang JJ, Mitchell P, Smith W, Cumming RG, Attebo K: Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 1999;40:12–19.
10.
Evans JR, Fletcher AE, Wormald RP: Depression and anxiety in visually impaired older people. Ophthalmology 2007;114:283–288.
11.
Waern M, Rubenowitz E, Runeson B, Skoog I, Wilhelmson K, Allebeck P: Burden of illness and suicide in elderly people: case-control study. BMJ 2002;324:1355.
12.
Lee DJ, Gomez-Marin O, Lam BL, Zheng DD: Visual acuity impairment and mortality in US adults. Arch Ophthalmol 2002;120:1544–1550.
13.
Pedula KL, Coleman AL, Hillier TA, Ensrud KE, Nevitt MC, Hochberg MC, Mangione CM: Visual acuity, contrast sensitivity, and mortality in older women: study of osteoporotic fractures. J Am Geriatr Soc 2006;54:1871–1877.
14.
Taylor HR, Pezzullo ML, Keeffe JE: The economic impact and cost of visual impairment in Australia. Br J Ophthalmol 2006;90:272–275.
15.
Taylor HR, Pezzullo ML, Nesbitt SJ, Keeffe JE: Costs of interventions for visual impairment. Am J Ophthalmol 2007;143:561– 565.
16.
Mojon-Azzi SM, Mojon DS: Strabismus and employment: the opinion of headhunters. Acta Ophthalmol 2008, E-pub ahead of print.
17.
Mojon-Azzi SM, Mojon DS: Opinion of headhunters about the ability of strabismic subjects to obtain employment. Ophthalmologica 2007;221:430–433.
18.
Coats DK, Paysse EA, Towler AJ, Dipboye RL: Impact of large angle horizontal strabismus on ability to obtain employment. Ophthalmology 2000;107:402–405.
19.
SHARE – Survey of Health, Aging and Retirement in Europe, 2005. www.share-project.org/.
20.
Börsch-Supan A, Jürges H: The Survey of Health, Aging, and Retirement in Europe – Methodology. Mannheim, Mannheim Research Institute for the Economics of Aging (MEA), 2005.
21.
McCullagh P: Regression models for ordinal data. J R Statist Soc B 1980;42:109–142.
22.
Rein DB, Zhang P, Wirth KE, Lee PP, Hoerger TJ, McCall N, Klein R, Tielsch JM, Vijan S, Saaddine J: The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 2006;124:1754–1760.
23.
Clark AE: What really matters in a job? Hedonic measurement using quit data. Labour Econ 2001;8:223–242.
24.
Clark AE, Georgellis Y, Sanfey P: Job satisfaction, wage changes and quits: evidence from Germany. Res Labor Econ 1998;17:95–121.
25.
Freeman RB: Job satisfaction as an economic variable. Am Econ Rev 1978;68:135–141.
26.
Faragher EB, Cass M, Cooper CL: The relationship between job satisfaction and health: a meta-analysis. Occup Environ Med 2005;62:105–112.
27.
Taylor HR, Keeffe JE, Vu HT, Wang JJ, Rochtchina E, Pezzullo ML, Mitchell P: Vision loss in Australia. Med J Aust 2005;182:565–568.
28.
Lightstone A: Eye health and sight loss: the UK vision strategy. J Fam Health Care 2008;18:162–164.
29.
Kocur I, Resnikoff S: Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol 2002;86:716–722.
30.
Fowles JB, Fowler EJ, Craft C: Validation of claims diagnoses and self-reported conditions compared with medical records for selected chronic diseases. J Ambul Care Manage 1998;21:24–34.
31.
Friedman SM, Munoz B, Rubin GS, West SK, Bandeen-Roche K, Fried LP: Characteristics of discrepancies between self-reported visual function and measured reading speed. Salisbury Eye Evaluation Project Team. Invest Ophthalmol Vis Sci 1999;40:858–864.
32.
Martin LM, Leff M, Calonge N, Garrett C, Nelson DE: Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000;18:215–218.
33.
Tisnado DM, Adams JL, Liu H, Damberg CL, Chen WP, Hu FA, Carlisle DM, Mangione CM, Kahn KL: What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care 2006;44:132–140.
34.
Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I: Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 1997;145:762–769.
35.
Wright SE, McCarty CA, Burgess M, Keeffe JE: Vision impairment and handicap: the RVIB Employment Survey. The Steering Committee for the RVIB Employment Survey. Aust NZ J Ophthalmol 1999;27:204–207.
36.
Mojon-Azzi SM, Sousa-Poza A, Mojon DS: Impact of low vision on well-being in 10 European countries. Ophthalmologica 2008;222:205–212.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.